Rheumatology
Service
Karolinska University Hospital
Estocolmo, SueciaPublications in collaboration with researchers from Karolinska University Hospital (29)
2024
-
Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
Kidney International Reports, Vol. 9, Núm. 6, pp. 1817-1835
2023
-
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
Annals of the rheumatic diseases, Vol. 81, Núm. 6, pp. 768-779
-
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
Rheumatology (Oxford, England), Vol. 61, Núm. 12, pp. 4741-4751
2021
-
HLA–B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti–Carbamylated Protein Antibody–Positive/Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis
Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 963-969
2020
-
Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2018
-
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 476-479
2017
-
EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases
Annals of the Rheumatic Diseases, Vol. 76, Núm. 4, pp. 639-646
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
-
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 3-15
2014
-
Multinational evidence-based recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
Annals of the Rheumatic Diseases, Vol. 73, Núm. 2, pp. 328-335
-
Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis
Arthritis Research and Therapy, Vol. 16, Núm. 4
2013
-
Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: A cumulative analysis of up to 4.6 years of exposure
Journal of Rheumatology, Vol. 40, Núm. 6, pp. 768-780
2012
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: Results of a 1-year follow-up study from the CERERRA collaboration
Annals of the Rheumatic Diseases, Vol. 71, Núm. 3, pp. 374-377
-
Variants within STAT genes reveal association with anticitrullinated protein antibody-negative rheumatoid arthritis in 2 European populations
Journal of Rheumatology, Vol. 39, Núm. 8, pp. 1509-1516
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196
2011
-
Algorithm for identification of undifferentiated peripheral inflammatory arthritis: A multinational collaboration through the 3e initiative
Journal of Rheumatology, Vol. 38, Núm. SUPPL. 87, pp. 54-58